ロード中...
Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice
BACKGROUND: The advent of oral disease-modifying therapies fundamentally changed the treatment of multiple sclerosis. Nevertheless, impressions of their relative efficacy and tolerability are primarily founded on expert opinion. OBJECTIVE: The purpose of this study was to determine whether oral dise...
保存先:
| 出版年: | Mult Scler J Exp Transl Clin |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340186/ https://ncbi.nlm.nih.gov/pubmed/28280599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217316677868 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|